Cardiovascular risk in the peritoneal dialysis patient
- PMID: 20567248
- DOI: 10.1038/nrneph.2010.68
Cardiovascular risk in the peritoneal dialysis patient
Abstract
Cardiovascular death is the most frequent cause of death in patients on peritoneal dialysis. Risk factors for cardiovascular death in these patients include those that affect the general population as well as those related to end-stage renal disease (ESRD) and those that are specific to peritoneal dialysis. The development of overhydration after loss of residual renal function is probably the most important cardiovascular risk factor specific to peritoneal dialysis. The high glucose load associated with peritoneal dialysis may lead to insulin resistance and to the development of an atherogenic lipid profile. The presence of glucose degradation products in conventional dialysis solutions, which leads to the local formation of advanced glycation end products, is also specific to peritoneal dialysis. Other risk factors that are not specific to peritoneal dialysis but are related to ESRD include calcifications and protein-energy wasting. When present together with inflammation and atherosclerosis, protein-energy wasting is associated with a marked increase in the risk of cardiovascular death. Obesity is not associated with increased cardiovascular risk in patients on any form of dialysis. Left ventricular hypertrophy and increased arterial stiffness are the most important risk factors for cardiovascular events in the general population.
Similar articles
-
Peritoneal dialysis and cardiovascular disease.Minerva Urol Nefrol. 2012 Sep;64(3):153-62. Minerva Urol Nefrol. 2012. PMID: 22971680
-
The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the Literature.Perit Dial Int. 2017 Jul-Aug;37(4):375-383. doi: 10.3747/pdi.2016.00228. Perit Dial Int. 2017. PMID: 28676508 Review.
-
Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease.Ann Intern Med. 2005 Aug 2;143(3):174-83. doi: 10.7326/0003-4819-143-3-200508020-00003. Ann Intern Med. 2005. PMID: 16061915
-
Strategies for improving long-term survival in peritoneal dialysis patients.Clin J Am Soc Nephrol. 2010 Jun;5(6):1123-31. doi: 10.2215/CJN.04300709. Epub 2010 Apr 29. Clin J Am Soc Nephrol. 2010. PMID: 20430945 Review.
-
Is peritoneal dialysis associated with increased cardiovascular morbidity and mortality?Perit Dial Int. 2006 Jul-Aug;26(4):429-34. Perit Dial Int. 2006. PMID: 16881336 Review. No abstract available.
Cited by
-
Coronary Artery Calcification Score as A Predictor of All-Cause Mortality and Cardiovascular Outcome in Peritoneal Dialysis Patients.Perit Dial Int. 2016 Mar-Apr;36(2):163-70. doi: 10.3747/pdi.2014.00124. Epub 2015 Jul 29. Perit Dial Int. 2016. PMID: 26224787 Free PMC article.
-
The association of peritoneal dialysis and hemodialysis on mitral and aortic valve calcification associated mortality: a meta-analysis.Sci Rep. 2024 Feb 27;14(1):4748. doi: 10.1038/s41598-024-55326-9. Sci Rep. 2024. PMID: 38413701 Free PMC article.
-
China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis.BMC Nephrol. 2012 Aug 30;13:94. doi: 10.1186/1471-2369-13-94. BMC Nephrol. 2012. PMID: 22935444 Free PMC article. Clinical Trial.
-
Long-term effects of spironolactone in peritoneal dialysis patients.J Am Soc Nephrol. 2014 May;25(5):1094-102. doi: 10.1681/ASN.2013030273. Epub 2013 Dec 12. J Am Soc Nephrol. 2014. PMID: 24335969 Free PMC article. Clinical Trial.
-
Relationship between Icodextrin use and decreased level of small low-density lipoprotein cholesterol fractioned by high-performance gel permeation chromatography.BMC Nephrol. 2013 Oct 26;14:234. doi: 10.1186/1471-2369-14-234. BMC Nephrol. 2013. PMID: 24161017 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical